Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with GYRE. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then GYRE could also see price increases.
| Ticker / NAME | Correlation To SPHDF | 1D Price Change % | ||
|---|---|---|---|---|
| SPHDF | 100% | N/A | ||
| GYRE - SPHDF | 82% Closely correlated | +11.84% | ||
| HRMY - SPHDF | 37% Loosely correlated | +1.86% | ||
| SPRC - SPHDF | 34% Loosely correlated | +4.43% | ||
| INM - SPHDF | 33% Poorly correlated | +1.77% | ||
| RVMD - SPHDF | 33% Poorly correlated | +1.55% | ||
More | ||||